1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Adler, M.
Seto, M.
Nitecki, D.
Light, D.R.
Morser, J.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
270
23366
23372
10.1074/jbc.270.40.23366
7559494
The structure of a 19-residue fragment from the C-loop of the fourth epidermal growth factor-like domain of thrombomodulin.
1995
10.2210/pdb1tmr/pdb
pdb_00001tmr
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
2073.396
THROMBOMODULIN PRECURSOR
1
man
polymer
no
no
VCAEGFAPIPGEPHRCQLF
VCAEGFAPIPGEPHRCQLF
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
sample
9606
Homo sapiens
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1995-06-08
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-03-02
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_struct_ref_seq_dif.details
Y
BNL
1994-05-20
REL
10
BIOSYM,INC.
refinement
DGII
VAL
1
n
1
VAL
1
A
CYS
2
n
2
CYS
2
A
ALA
3
n
3
ALA
3
A
GLU
4
n
4
GLU
4
A
GLY
5
n
5
GLY
5
A
PHE
6
n
6
PHE
6
A
ALA
7
n
7
ALA
7
A
PRO
8
n
8
PRO
8
A
ILE
9
n
9
ILE
9
A
PRO
10
n
10
PRO
10
A
GLY
11
n
11
GLY
11
A
GLU
12
n
12
GLU
12
A
PRO
13
n
13
PRO
13
A
HIS
14
n
14
HIS
14
A
ARG
15
n
15
ARG
15
A
CYS
16
n
16
CYS
16
A
GLN
17
n
17
GLN
17
A
LEU
18
n
18
LEU
18
A
PHE
19
n
19
PHE
19
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
8.40
1.30
111.50
119.90
A
A
A
ND1
CE1
NE2
HIS
HIS
HIS
14
14
14
N
1
4.54
0.50
120.30
124.84
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
15
15
15
N
2
8.39
1.30
111.50
119.89
A
A
A
ND1
CE1
NE2
HIS
HIS
HIS
14
14
14
N
2
4.57
0.50
120.30
124.87
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
15
15
15
N
3
8.42
1.30
111.50
119.92
A
A
A
ND1
CE1
NE2
HIS
HIS
HIS
14
14
14
N
3
4.53
0.50
120.30
124.83
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
15
15
15
N
4
8.47
1.30
111.50
119.97
A
A
A
ND1
CE1
NE2
HIS
HIS
HIS
14
14
14
N
4
4.51
0.50
120.30
124.81
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
15
15
15
N
5
8.44
1.30
111.50
119.94
A
A
A
ND1
CE1
NE2
HIS
HIS
HIS
14
14
14
N
5
4.54
0.50
120.30
124.84
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
15
15
15
N
6
8.50
1.30
111.50
120.00
A
A
A
ND1
CE1
NE2
HIS
HIS
HIS
14
14
14
N
6
4.56
0.50
120.30
124.86
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
15
15
15
N
7
8.46
1.30
111.50
119.96
A
A
A
ND1
CE1
NE2
HIS
HIS
HIS
14
14
14
N
7
4.57
0.50
120.30
124.87
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
15
15
15
N
8
8.43
1.30
111.50
119.93
A
A
A
ND1
CE1
NE2
HIS
HIS
HIS
14
14
14
N
8
4.62
0.50
120.30
124.92
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
15
15
15
N
9
8.49
1.30
111.50
119.99
A
A
A
ND1
CE1
NE2
HIS
HIS
HIS
14
14
14
N
9
4.56
0.50
120.30
124.86
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
15
15
15
N
10
8.43
1.30
111.50
119.93
A
A
A
ND1
CE1
NE2
HIS
HIS
HIS
14
14
14
N
10
4.56
0.50
120.30
124.86
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
15
15
15
N
1
A
A
CD
OE2
GLU
GLU
4
4
0.108
0.011
1.252
1.360
N
1
A
A
CD
OE2
GLU
GLU
12
12
0.112
0.011
1.252
1.364
N
2
A
A
CD
OE2
GLU
GLU
4
4
0.109
0.011
1.252
1.361
N
2
A
A
CD
OE2
GLU
GLU
12
12
0.112
0.011
1.252
1.364
N
3
A
A
CD
OE2
GLU
GLU
4
4
0.108
0.011
1.252
1.360
N
3
A
A
CD
OE2
GLU
GLU
12
12
0.112
0.011
1.252
1.364
N
4
A
A
CD
OE2
GLU
GLU
4
4
0.107
0.011
1.252
1.359
N
4
A
A
CD
OE2
GLU
GLU
12
12
0.111
0.011
1.252
1.363
N
4
A
A
CG
CD2
HIS
HIS
14
14
0.055
0.009
1.354
1.409
N
5
A
A
CD
OE2
GLU
GLU
4
4
0.108
0.011
1.252
1.360
N
5
A
A
CD
OE2
GLU
GLU
12
12
0.113
0.011
1.252
1.365
N
6
A
A
CD
OE2
GLU
GLU
4
4
0.107
0.011
1.252
1.359
N
6
A
A
CD
OE2
GLU
GLU
12
12
0.112
0.011
1.252
1.364
N
7
A
A
CD
OE2
GLU
GLU
4
4
0.108
0.011
1.252
1.360
N
7
A
A
CD
OE2
GLU
GLU
12
12
0.111
0.011
1.252
1.363
N
8
A
A
CD
OE2
GLU
GLU
4
4
0.108
0.011
1.252
1.360
N
8
A
A
CD
OE2
GLU
GLU
12
12
0.111
0.011
1.252
1.363
N
9
A
A
CD
OE2
GLU
GLU
4
4
0.107
0.011
1.252
1.359
N
9
A
A
CD
OE2
GLU
GLU
12
12
0.113
0.011
1.252
1.365
N
10
A
A
CD
OE2
GLU
GLU
4
4
0.110
0.011
1.252
1.362
N
10
A
A
CD
OE2
GLU
GLU
12
12
0.112
0.011
1.252
1.364
N
10
A
A
CG
CD2
HIS
HIS
14
14
0.055
0.009
1.354
1.409
N
1
A
CYS
2
-166.55
-124.51
1
A
ALA
7
174.22
165.84
1
A
PRO
8
-54.85
176.76
1
A
PRO
10
-63.33
98.64
1
A
PRO
13
-87.58
37.30
1
A
CYS
16
-102.36
-160.66
1
A
GLN
17
-168.53
-134.26
2
A
CYS
2
-165.58
-97.59
2
A
GLU
4
-68.50
94.39
2
A
PRO
8
-56.74
178.41
2
A
PRO
13
-79.96
31.84
2
A
ARG
15
-120.75
-168.15
2
A
GLN
17
-159.44
-135.36
3
A
CYS
2
-93.31
-86.87
3
A
PRO
8
-63.52
-160.18
3
A
PRO
13
-87.51
43.97
3
A
GLN
17
-178.21
-132.50
4
A
CYS
2
69.82
-94.31
4
A
PRO
8
-60.60
-175.91
4
A
PRO
13
-82.35
30.03
4
A
GLN
17
-132.83
-146.75
5
A
CYS
2
78.79
-89.71
5
A
ALA
3
169.49
147.67
5
A
PRO
8
-57.07
178.13
5
A
PRO
13
-80.25
31.70
5
A
GLN
17
-141.41
-146.23
6
A
CYS
2
50.65
-98.51
6
A
ALA
3
169.04
158.48
6
A
PRO
13
-84.69
39.08
6
A
CYS
16
-103.45
-169.43
6
A
GLN
17
-175.04
-125.12
7
A
CYS
2
-169.29
-96.92
7
A
GLU
4
-69.04
89.91
7
A
PRO
8
-55.41
176.74
7
A
PRO
13
-84.81
37.38
7
A
GLN
17
-82.77
-141.61
8
A
CYS
2
-159.79
-85.76
8
A
PRO
8
-55.72
173.99
8
A
PRO
13
-77.89
29.80
8
A
GLN
17
-112.40
-122.72
9
A
CYS
2
43.71
-108.85
9
A
ALA
3
168.41
132.22
9
A
GLU
4
-55.16
93.06
9
A
PRO
8
-62.89
-173.74
9
A
PRO
13
-87.48
39.63
9
A
CYS
16
-88.96
-157.67
9
A
GLN
17
-171.44
-57.97
10
A
CYS
2
52.33
-94.48
10
A
PRO
8
-61.64
-178.12
10
A
PRO
13
-85.88
37.06
10
A
GLN
17
-147.86
-52.55
THE STRUCTURE OF A 19 RESIDUE FRAGMENT FROM THE C-LOOP OF THE FOURTH EPIDERMAL GROWTH FACTOR-LIKE DOMAIN OF THROMBOMODULIN
1
Y
N
disulf
2.064
A
CYS
2
A
SG
CYS
2
1_555
A
CYS
16
A
SG
CYS
16
1_555
BLOOD COAGULATION
BLOOD COAGULATION
TRBM_HUMAN
UNP
1
1
P07204
MLGVLVLGALALAGLGFPAPAEPQPGGSQCVEHDCFALYPGPATFLNASQICDGLRGHLMTVRSSVAADVISLLLNGDGG
VGRRRLWIGLQLPPGCGDPKRLGPLRGFQWVTGDNNTSYSRWARLDLNGAPLCGPLCVAVSAAEATVPSEPIWEEQQCEV
KADGFLCEFHFPATCRPLAVEPGAAAAAVSITYGTPFAARGADFQALPVGSSAAVAPLGLQLMCTAPPGAVQGHWAREAP
GAWDCSVENGGCEHACNAIPGAPRCQCPAGAALQADGRSCTASATQSCNDLCEHFCVPNPDQPGSYSCMCETGYRLAADQ
HRCEDVDDCILEPSPCPQRCVNTQGGFECHCYPNYDLVDGECVEPVDPCFRANCEYQCQPLNQTSYLCVCAEGFAPIPHE
PHRCQMFCNQTACPADCDPNTQASCECPEGYILDDGFICTDIDECENGGFCSGVCHNLPGTFECICGPDSALARHIGTDC
DSGKVDGGDSGSGEPPPSPTPGSTLTPPAVGLVHSGLLIGISIASLCLVVALLALLCHLRKKQGAARAKMEYKCAAPSKE
VVLQHVRTERTPQRL
389
407
1TMR
1
19
P07204
A
1
1
19
1
HIS
conflict
GLY
11
1TMR
A
P07204
UNP
399
11
1
MET
conflict
LEU
18
1TMR
A
P07204
UNP
406
18
1
P 1